US FDA’s Patient Input Guidance Opens Door Wider To Social Media Data Collection

Following stakeholder criticism of an earlier discussion paper, draft guidance does not automatically foreclose use of social media data as the primary source of qualitative research; however, agency says entities submitting such data for regulatory review must ensure rigor in methodology and data integrity.

KIEV, UKRAINE - MAY 18, 2015:Collection of popular social media logos printed on paper:Facebook, Twitter, Google Plus, Instagram, Skype, WhatsApp, Pinterest, Blogger and others on white background

More from Clinical Trials

More from R&D